tetano
Editor, Senior Moderator
Pulmonology
. 2021 Sep 20;S2531-0437(21)00189-6.
doi: 10.1016/j.pulmoe.2021.08.012. Online ahead of print.
Practice of tracheostomy in patients with acute respiratory failure related to COVID-19 - Insights from the PRoVENT-COVID study
A M Tsonas[SUP] 1 [/SUP], M Botta[SUP] 2 [/SUP], J Horn[SUP] 3 [/SUP], M J Brenner[SUP] 4 [/SUP], M S Teng[SUP] 5 [/SUP], B A McGrath[SUP] 6 [/SUP], M J Schultz[SUP] 7 [/SUP], F Paulus[SUP] 8 [/SUP], A Serpa Neto[SUP] 9 [/SUP], PRoVENT–COVID Collaborative Group
Affiliations
Abstract
Objective: Invasively ventilated patients with acute respiratory failure related to coronavirus disease 2019 (COVID-19) potentially benefit from tracheostomy. The aim of this study was to determine the practice of tracheostomy during the first wave of the pandemic in 2020 in the Netherlands, to ascertain whether timing of tracheostomy had an association with outcome, and to identify factors that had an association with timing.
Methods: Secondary analysis of the 'PRactice of VENTilation in COVID-19' (PRoVENT-COVID) study, a multicenter observational study, conducted from March 1, 2020 through June 1, 2020 in 22 Dutch intensive care units (ICU) in the Netherlands. The primary endpoint was the proportion of patients receiving tracheostomy; secondary endpoints were timing of tracheostomy, duration of ventilation, length of stay in ICU and hospital, mortality, and factors associated with timing.
Results: Of 1023 patients, 189 patients (18.5%) received a tracheostomy at median 21 [17 to 28] days from start of ventilation. Timing was similar before and after online publication of an amendment to the Dutch national guidelines on tracheostomy focusing on COVID-19 patients (21 [17-28] vs. 21 [17-26] days). Tracheostomy performed ≤ 21 days was independently associated with shorter duration of ventilation (median 26 [21 to 32] vs. 40 [34 to 47] days) and higher mortality in ICU (22.1% vs. 10.2%), hospital (26.1% vs. 11.9%) and at day 90 (27.6% vs. 14.6%). There were no patient demographics or ventilation characteristics that had an association with timing of tracheostomy.
Conclusions: Tracheostomy was performed late in COVID-19 patients during the first wave of the pandemic in the Netherlands and timing of tracheostomy possibly had an association with outcome. However, prospective studies are needed to further explore these associations. It remains unknown which factors influenced timing of tracheostomy in COVID-19 patients.
Keywords: ARDS; Acute respiratory failure; Coronavirus 2019; Covid-19; SARS-COV-2; Tracheostomy; Ventilation management.
. 2021 Sep 20;S2531-0437(21)00189-6.
doi: 10.1016/j.pulmoe.2021.08.012. Online ahead of print.
Practice of tracheostomy in patients with acute respiratory failure related to COVID-19 - Insights from the PRoVENT-COVID study
A M Tsonas[SUP] 1 [/SUP], M Botta[SUP] 2 [/SUP], J Horn[SUP] 3 [/SUP], M J Brenner[SUP] 4 [/SUP], M S Teng[SUP] 5 [/SUP], B A McGrath[SUP] 6 [/SUP], M J Schultz[SUP] 7 [/SUP], F Paulus[SUP] 8 [/SUP], A Serpa Neto[SUP] 9 [/SUP], PRoVENT–COVID Collaborative Group
Affiliations
- PMID: 34836830
- DOI: 10.1016/j.pulmoe.2021.08.012
Abstract
Objective: Invasively ventilated patients with acute respiratory failure related to coronavirus disease 2019 (COVID-19) potentially benefit from tracheostomy. The aim of this study was to determine the practice of tracheostomy during the first wave of the pandemic in 2020 in the Netherlands, to ascertain whether timing of tracheostomy had an association with outcome, and to identify factors that had an association with timing.
Methods: Secondary analysis of the 'PRactice of VENTilation in COVID-19' (PRoVENT-COVID) study, a multicenter observational study, conducted from March 1, 2020 through June 1, 2020 in 22 Dutch intensive care units (ICU) in the Netherlands. The primary endpoint was the proportion of patients receiving tracheostomy; secondary endpoints were timing of tracheostomy, duration of ventilation, length of stay in ICU and hospital, mortality, and factors associated with timing.
Results: Of 1023 patients, 189 patients (18.5%) received a tracheostomy at median 21 [17 to 28] days from start of ventilation. Timing was similar before and after online publication of an amendment to the Dutch national guidelines on tracheostomy focusing on COVID-19 patients (21 [17-28] vs. 21 [17-26] days). Tracheostomy performed ≤ 21 days was independently associated with shorter duration of ventilation (median 26 [21 to 32] vs. 40 [34 to 47] days) and higher mortality in ICU (22.1% vs. 10.2%), hospital (26.1% vs. 11.9%) and at day 90 (27.6% vs. 14.6%). There were no patient demographics or ventilation characteristics that had an association with timing of tracheostomy.
Conclusions: Tracheostomy was performed late in COVID-19 patients during the first wave of the pandemic in the Netherlands and timing of tracheostomy possibly had an association with outcome. However, prospective studies are needed to further explore these associations. It remains unknown which factors influenced timing of tracheostomy in COVID-19 patients.
Keywords: ARDS; Acute respiratory failure; Coronavirus 2019; Covid-19; SARS-COV-2; Tracheostomy; Ventilation management.